Available evidence supports the hypothesis that adjuvant chemotherapy for breast cancer
can produce cognitive deficits, and that these deficits may have a significant impact on …

Being diagnosed with cancer and undergoing treatment can be a daunting experience. The
side effects of treatment often influence a person's quality of life. One side effect that has …

Cognitive decline is a common health problem among breast cancer patients and
understanding trajectories of cognitive change following among breast cancer survivors is …

Purpose/Objectives: To describe the cognitive dysfunction experienced by two women after
they received adjuvant chemotherapy for breast cancer and to discuss the potential role of …

Background and Purpose The purpose of this secondary analysis was to examine the
reliability and validity of the Patient Assessment of Own Functioning Inventory (PAOFI) in …

With an estimated 207,090 patients diagnosed with breast cancer in 2010, the role of
chemotherapy-induced cognitive impairment is of growing importance. Studies to determine …

This study investigated the effects of endocrine therapy (ie, tamoxifen and anastrozole) on
cognitive functioning by comparing 28 postmenopausal women with breast cancer to 37 …

De nombreux patients traités par chimiothérapies pour des cancers systémiques sans
atteinte du système nerveux central présentent des plaintes faisant évoquer une atteinte des …

Over two-thirds of women with breast cancer have positive tumors for hormone receptors,
and these patients undergo treatment with endocrine therapy, tamoxifen being the most …

OBJECTIVES: To provide an overview of chemotherapy-related cognitive dysfunction in
breast cancer survivors, focusing on its pathophysiology, risk factors, assessment, and …